Company intelligence / Profile preview

Oral Care

United States

Ownership: Private
Development stage: Other

Overview

Pre-clinical data shows Ambrilux Dental Gel regenerates bone tissue lost to periodontal disease in one month of therapy, outperforming standard of care.

Therapeutic areas: Other
Modalities: Device
Industry: Veterinary

Partnerships

Global top-tier animal health pharma organization (licensed Ambrilux Dental Gel for canines)

Beyond the preview

Go deeper on Oral Care.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oral Care.

Explore the full profile